Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Two new appointments at Cerulean Pharma

This article was originally published in Scrip

Executive Summary

Cerulean Pharma, a US biopharmaceutical company focused on nanoparticle-based drugs, has appointed Dr John Ryan senior vice-president and chief medical officer and Karen Roberts senior vice-president of finance and administration. Dr Ryan has more than 20 years' experience in clinical research and development at AVEO Pharmaceuticals, Wyeth (formerly Genetics Institute) and Merck Research Laboratories. He most recently served as chief medical officer at AVEO, where he built a clinical group for the development of oncology drugs. Ms Roberts joins from Elixir Pharmaceuticals, where she previously served as vice-president of finance and administration.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts